Randomised study to compare aspirin versus hydroxyurea/aspirin in 'intermediate risk' primary thrombocythaemia (PT) and hydroxyurea/aspirin versus anagrelide/aspirin in 'high risk' primary thrombocythaemia

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2000
This article has no abstract
Epistemonikos ID: 0fe3a65acf30cd4fbc1996a9ead73653f4402d29
First added on: Jan 17, 2025